CrossBridge Bio
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd Ste X, Houston, Texas...Website
www.crossbridgebio.comRevenue
<$5 MillionIndustry
About CrossBridge Bio
CrossBridge Bio Org Chart
Is CrossBridge Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CrossBridge Bio recently announced quarterly report
Click to see if CrossBridge Bio had a recent Job posting/layoffs
Check out if CrossBridge Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CrossBridge Bio
Website visits: Recent activity has been detected on your website
CrossBridge Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CrossBridge Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CrossBridge Bio launches new products
Funding: Get notified immidiatlly once CrossBridge Bio has new funding data
Recommended Actions
Find VP level buyers at CrossBridge Bio
Find 3 more new buyers
Company Profile Activity
Activity Insights
CrossBridge Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CrossBridge Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CrossBridge Bio.
CrossBridge Bio financials insights
Gather financial insights about CrossBridge Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$10M
CrossBridge Bio Tech Stack
A closer look at the technologies used by CrossBridge Bio
Most Recent Scoops
CrossBridge Bio News & Media
Eli Lilly bets $300m on CrossBridge Bio's dual-payload ADC platform - BioXconomy
Eli Lilly is expanding its oncology pipeline with the acquisition of CrossBridge Bio, a Texas-based biotech specializing in dual-payload ADCs.CrossBridge Bio: $15 Million CPRIT Grant Raised To Advance Lead Dual Payload ADC ...
CrossBridge Bio has received a $15 million grant from the Cancer Prevention and Research Institute of Texas, marking a significant milestone in the company’s effort to bring its lead dual payload antibody drug conjugate, CBB 120, into the clinic. The Houston-based biotechnology company is developing next-generation ADCs designed to offer safer and more durable responses for patients, including those who no longer benefit from approved ADC therapies.
Top Manufacturing Companies
Frequently Asked Questions Regarding CrossBridge Bio
Based in Houston, Texas, CrossBridge Bio aims to overcome the shortcomings seen with current ADCs to deliver better therapeutics for patients.... Read More